Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:231654rdf:typepubmed:Citationlld:pubmed
pubmed-article:231654lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:231654lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:231654lifeskim:mentionsumls-concept:C0205460lld:lifeskim
pubmed-article:231654lifeskim:mentionsumls-concept:C0871161lld:lifeskim
pubmed-article:231654lifeskim:mentionsumls-concept:C0049574lld:lifeskim
pubmed-article:231654pubmed:issue12lld:pubmed
pubmed-article:231654pubmed:dateCreated1980-5-14lld:pubmed
pubmed-article:231654pubmed:abstractText2-Fluoro-, 5-fluoro- and 6-fluorodimethoxybenzaldehydes were prepared by photochemical decomposition of the corresponding diazonium fluoroborates. The aldehydes were converted to the cyanohydrin trimethylsilyl ethers, which, in turn, were reduced to the dimethoxyphenethanolamines. Boron tribromide demethylation afforded the racemic ring-fluorinated norepinephrines. An alternate route, using the dibenzyloxyfluoroaldehyde, was also used to prepare 6-fluoronorepinephrine. The fluorine substituent markedly increases the phenolic acidities of these analogues. The biological properties conferred upon norepinephrine by the fluorine substituents in peripheral and central adrenergically responsive systems clearly demonstrate that 2-fluoronorepinephrine is a nearly a pure beta-adrenergic agonist, while 6-fluoronorepinephrine is an alpha-adrenergic agonist. 5-Fluoronorepinephrine retains both beta- and alpha-adrenergic agonist properties. Receptor-binding studies with specific radiolabeled ligands indicate that the specificity conferred by the site of fluorine substituents results from a change in the affinity of these analogues for the alpha- and beta-adrenergic receptors.lld:pubmed
pubmed-article:231654pubmed:languageenglld:pubmed
pubmed-article:231654pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:231654pubmed:citationSubsetIMlld:pubmed
pubmed-article:231654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:231654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:231654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:231654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:231654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:231654pubmed:statusMEDLINElld:pubmed
pubmed-article:231654pubmed:monthDeclld:pubmed
pubmed-article:231654pubmed:issn0022-2623lld:pubmed
pubmed-article:231654pubmed:authorpubmed-author:CrevelingC...lld:pubmed
pubmed-article:231654pubmed:authorpubmed-author:DalyJ WJWlld:pubmed
pubmed-article:231654pubmed:authorpubmed-author:KirkK LKLlld:pubmed
pubmed-article:231654pubmed:authorpubmed-author:Nimitkitpaisa...lld:pubmed
pubmed-article:231654pubmed:authorpubmed-author:CantacuzeneDDlld:pubmed
pubmed-article:231654pubmed:authorpubmed-author:McCullohDDlld:pubmed
pubmed-article:231654pubmed:authorpubmed-author:PadgettW LWLlld:pubmed
pubmed-article:231654pubmed:issnTypePrintlld:pubmed
pubmed-article:231654pubmed:volume22lld:pubmed
pubmed-article:231654pubmed:ownerNLMlld:pubmed
pubmed-article:231654pubmed:authorsCompleteYlld:pubmed
pubmed-article:231654pubmed:pagination1493-7lld:pubmed
pubmed-article:231654pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:231654pubmed:meshHeadingpubmed-meshheading:231654-A...lld:pubmed
pubmed-article:231654pubmed:meshHeadingpubmed-meshheading:231654-B...lld:pubmed
pubmed-article:231654pubmed:meshHeadingpubmed-meshheading:231654-G...lld:pubmed
pubmed-article:231654pubmed:meshHeadingpubmed-meshheading:231654-R...lld:pubmed
pubmed-article:231654pubmed:meshHeadingpubmed-meshheading:231654-F...lld:pubmed
pubmed-article:231654pubmed:meshHeadingpubmed-meshheading:231654-M...lld:pubmed
pubmed-article:231654pubmed:meshHeadingpubmed-meshheading:231654-N...lld:pubmed
pubmed-article:231654pubmed:meshHeadingpubmed-meshheading:231654-M...lld:pubmed
pubmed-article:231654pubmed:meshHeadingpubmed-meshheading:231654-M...lld:pubmed
pubmed-article:231654pubmed:meshHeadingpubmed-meshheading:231654-M...lld:pubmed
pubmed-article:231654pubmed:meshHeadingpubmed-meshheading:231654-V...lld:pubmed
pubmed-article:231654pubmed:meshHeadingpubmed-meshheading:231654-B...lld:pubmed
pubmed-article:231654pubmed:meshHeadingpubmed-meshheading:231654-C...lld:pubmed
pubmed-article:231654pubmed:meshHeadingpubmed-meshheading:231654-S...lld:pubmed
pubmed-article:231654pubmed:meshHeadingpubmed-meshheading:231654-R...lld:pubmed
pubmed-article:231654pubmed:meshHeadingpubmed-meshheading:231654-R...lld:pubmed
pubmed-article:231654pubmed:year1979lld:pubmed
pubmed-article:231654pubmed:articleTitleSynthesis and biological properties of 2-, 5-, and 6-fluoronorepinephrines.lld:pubmed
pubmed-article:231654pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:231654pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:231654lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:231654lld:pubmed